Fundamental analysis by بورس24 | Bourse24 about Stock شیران on 2/5/2024

📢 Browsing Kodal reports #Shiran ✅ The performance of D this month The chemical giant ended up with a revenue of 764 billion, almost 317 billion more than the same period. It is noteworthy that the company has a much more active presence in the export markets and has been able to increase the export income of its strategic product, linear alkylbenzene, by more than 4.1 times, from 28 to more than 115 billion tomans. ✅ Recently, it has acquired 100% shares of Arash Elixir Chemical Industries Company. Following this action, the ownership and development of the ethylene product production plan D Amen to Shiran has been transferred and this means stabilizing and strengthening the company's position in the industry as well as diversifying the income portfolio of products. Of course, it should be noted that this project is being implemented for the first time in the country and practically Sahme-Shiran' target='_blank'>Shiran is the only player in the above product market (exclusive market for ethylene product Di Amen). ✅ The market is waiting for the financial statements of the 1402 period of this chemical giant. The company has reached a net profit of 2.5 thousand billion in the 9-month scale and according to the monthly reports, the cumulative value of the revenues of the financial period of 1402 is calculated to be approximately 8.7 hemat, assuming a net profit margin of 41%. /sahmeto.com/ticker/IRT3TVAF0001/overall-results-of-buy-and-sell-signals-toan-share' target='_blank'>toan expected a profit of 3.5 to 3.6 hemti. Technically, since the beginning of summer, it has fluctuated within a medium-term channel with a floor of 420 tomans and a ceiling of 535 tomans. Over the past year, with the price reaching from 320 to more than 750 tomans, it has presented more than 130% of capital gains to shareholders. #⃣ #pulse_bazar 🔗 The pulse of the stock market @bourse24ir